Related Experiment Videos
Adrenal tumors: how to establish malignancy ?
M Fassnacht1, W Kenn, B Allolio
1Endocrinology and Diabetes Unit, University of Wuerzburg, Germany.
Journal of Endocrinological Investigation
|July 6, 2004
Summary
Accurately diagnosing adrenal tumors is crucial for patient care. Imaging techniques like CT and MRI, alongside tumor size and biopsy, help determine malignancy, guiding treatment decisions.
Area of Science:
- Endocrinology
- Radiology
- Oncology
Background:
- Distinguishing malignant from benign adrenal tumors is critical for effective patient management.
- Clinical and hormonal evaluations offer limited predictive value for adrenal tumor malignancy.
Purpose of the Study:
- To review and summarize current diagnostic tools for characterizing adrenal tumors, focusing on differentiating benign from malignant lesions.
Main Methods:
- Review of imaging modalities including computed tomography (CT) and magnetic resonance imaging (MRI) for adrenal mass characterization.
- Discussion of tumor size, enhancement patterns, and signal intensity on MRI as indicators of malignancy.
- Consideration of fine needle aspiration/biopsy and emerging diagnostic scores and immunohistological markers.
Main Results:
- Tumor size is a significant factor, with lesions <3 cm typically benign and >6 cm indicating high malignancy risk.
- Specific CT (attenuation, enhancement washout) and MRI (opposed-phase imaging, T2 signal intensity) features help differentiate adenomas from carcinomas.
- Adrenal carcinomas often present as inhomogeneous lesions with irregular margins and enhancement.
Conclusions:
- An integrated, interdisciplinary approach utilizing structured diagnostic tools is essential for accurate adrenal tumor classification.
- Imaging findings, tumor characteristics, and biopsy results collectively inform decisions on follow-up or surgical intervention.
- Continued development of diagnostic scores and immunohistological markers may further improve malignancy assessment.